Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death
United European Gastroenterology Journal · 2026
DOI: 10.1002/ueg2.70131 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Caroline Schwarz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Klinik Ottakring, Vienna, Austria. Hauptthemen laut MEDLINE: Portasystemic Shunt, Transjugular Intrahepatic, Alcohol Drinking, Hypertension, Portal, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Christian Doppler Forschungsgesellschaft, Clinical Research Groups Program of the Ludwig Boltzmann Gesellschaft, Austrian Federal Ministry for Digital and Economic Affairs.
Abstract (Originalsprache)
Background
Complications related to portal hypertension (PH) in patients with alcohol‐related liver disease (ALD) can be controlled by transjugular intrahepatic portosystemic shunt (TIPS) placement; however, the impact of ongoing alcohol use (AU) after TIPS remains scarcely investigated.
Methods
ALD patients undergoing TIPS implantation between 2000 and 2022 were included. Laboratory/demographic parameters and clinical events/outcomes were compared per post‐TIPS AU status and to a group of n = 55 decompensated ALD patients with ongoing AU who did not receive TIPS.
Results
Overall, 248 TIPS patients (78.2% male; median age: 55.5 years; ascites: 69.8%; median MELD: 12), including 90 (36.3%) with ongoing AU after TIPS were included. AU post‐TIPS was independently associated with ACLF (asHR 2.27; 95% CI 1.40–3.66; p < 0.001) and liver‐related death (asHR 1.68; 95% CI 1.05–2.67; p = 0.030) among patients undergoing TIPS in adjusted multivariable competing risks analysis. When comparing matched decompensated AU patients treated versus non‐treated by TIPS, multivariable competing risks regression revealed MELD (asHR 1.07; 95% CI 1.01–1.13; p = 0.033) but not TIPS use (asHR 0.70; 95% CI 0.45–1.10; p = 0.120) as independent risk factors for ACLF, despite TIPS patients having higher levels of systemic inflammation (CRP).
Conclusion
Post‐TIPS AU was frequent and an independent risk factor for ACLF and liver‐related death, underlining the importance of interdisciplinary measures supporting alcohol abstinence. TIPS should still not be withheld from ALD patients developing PH complications, since it does not predispose them to ACLF and may prevent liver‐related death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine IV, Klinik Ottakring, Vienna, Austria.
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Clinical Research Group MOTION, Medical University of Vienna, Vienna, Austria.
- Department of Internal Medicine II, University Clinic of St. Poelten, St. Poelten, Austria.
- Christian Doppler Lab for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Caroline Schwarz, Benedikt S Hofer, Nina Dominik, Georg Kramer, Benedikt Simbrunner, Mathias Jachs, Mattias Mandorfer, Lukas Hartl
Förderung
- Christian Doppler Forschungsgesellschaft
- Clinical Research Groups Program of the Ludwig Boltzmann Gesellschaft
- Austrian Federal Ministry for Digital and Economic Affairs
- Boehringer Ingelheim
- Österreichische Gesellschaft für Gastroenterologie und Hepatologie
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
Zitieren
APA
Schwarz, C., Kornfehl, A., Abid, R., Müllner-Bucsics, T., Kappel, J., Schwarz, M., Hofer, B. S., Dominik, N., Kramer, G., Simbrunner, B., Jachs, M., Reider, L., Trauner, M., Mandorfer, M., Reiberger, T., & Hartl, L. (2026). Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70131
Vancouver
Schwarz C, Kornfehl A, Abid R, Müllner-Bucsics T, Kappel J, Schwarz M, et al. Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70131
BibTeX
@article{Schwarz2026,
author = {Schwarz, Caroline and Kornfehl, Andrea and Abid, Reema and Müllner-Bucsics, Theresa and Kappel, Julia and Schwarz, Michael and Hofer, Benedikt S and Dominik, Nina and Kramer, Georg and Simbrunner, Benedikt and Jachs, Mathias and Reider, Lukas and Trauner, Michael and Mandorfer, Mattias and Reiberger, Thomas and Hartl, Lukas},
title = {Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death},
journal = {United European Gastroenterology Journal},
year = {2026},
doi = {10.1002/ueg2.70131}
}
EUVIMED